What to Expect When Switching to a Biosimilar: A US Healthcare Professional’s Perspective

As biosimilars become more available, many patients with inflammatory bowel disease may experience having their treatment switched from a reference product to a biosimilar. In this communication, a physician assistant and a pharmacist discuss the patient experience when switching to a biosimilar.

Authors

Institutions

Publication Details

Journal
Crohn s & Colitis 360
Published
2024-10-01
DOI
https://doi.org/10.1093/crocol/otae063
Primary Topic
Biosimilars and Bioanalytical Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What to Expect When Switching to a Biosimilar: A US Healthcare Professional’s Perspective

Juanita Belton, Nicholas D’Apice
Crohn s & Colitis 360
Biosimilars and Bioanalytical Methods
article

What to Expect When Switching to a Biosimilar: A US Healthcare Professional’s Perspective

Juanita Belton, Nicholas D’Apice
article en

Abstract

As biosimilars become more available, many patients with inflammatory bowel disease may experience having their treatment switched from a reference product to a biosimilar. In this communication, a physician assistant and a pharmacist discuss the patient experience when switching to a biosimilar.

Crohn s & Colitis 360Vol. 6(4)
Boston Medical Center (US)
Boehringer Ingelheim
Openalex Percentile: Top 72%
Biosimilars and Bioanalytical Methods
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

What to Expect When Switching to a Biosimilar: A US Healthcare Professional’s Perspective — Juanita Belton, Nicholas D’Apice · Crohn s & Colitis 360 (2024) | TGRS Research Map | TGRS